Hui Lyu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Cell death mechanisms and regulation 3
- RNA Interference and Gene Delivery 3
- PI3K/AKT/mTOR signaling in cancer 3
- Glycosylation and Glycoproteins Research 2
- Protein Degradation and Inhibitors 2
- Oncology 19
- HER2/EGFR in Cancer Research 12
- Co-authors
- Bolin Liu (27 shared papers)Jingcao Huang (11 shared papers)Jian Ma (2 shared papers)Zhimin He (8 shared papers)Jianxiang Wang (3 shared papers)Shuiliang Wang (4 shared papers)Shuang Liu (1 shared paper)Hongbing Liu (1 shared paper)
- Journals
- Cancer Letters (4 papers)Cancer Research (4 papers)Biological Procedures Online (3 papers)Journal of Cellular Biochemistry (2 papers)Molecular Cancer (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Hui Lyu
33 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 79
- Cancer Research 255
- Oncology 441
- Radiology, Nuclear Medicine and Imaging 181
- Molecular Biology 562
- Pulmonary and Respiratory Medicine 115
Countries citing papers authored by Hui Lyu
This map shows the geographic impact of Hui Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Lyu more than expected).
Fields of papers citing papers by Hui Lyu
This network shows the impact of papers produced by Hui Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Lyu. The network helps show where Hui Lyu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Lyu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 145 | |
| 2 | 2016 | 101 | |
| 3 | 2018 | 93 | |
| 4 | 2022 | 78 | |
| 5 | MicroRNA regulation and therapeutic targeting of survivin in cancer. | 2015 | 75 |
| 6 | 2021 | 69 | |
| 7 | 2013 | 54 | |
| 8 | 2019 | 50 | |
| 9 | 2018 | 47 | |
| 10 | 2013 | 42 | |
| 11 | 2014 | 37 | |
| 12 | 2018 | 32 | |
| 13 | 2015 | 28 | |
| 14 | 2013 | 25 | |
| 15 | 2015 | 22 | |
| 16 | 2018 | 15 | |
| 17 | 2021 | 14 | |
| 18 | 2023 | 12 | |
| 19 | 2018 | 12 | |
| 20 | Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells. | 2015 | 10 |
About Hui Lyu
Hui Lyu is a scholar working on Molecular Biology, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Cell death mechanisms and regulation (3 papers), RNA Interference and Gene Delivery (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Cancer Research (255 citations), Oncology (441 citations), Radiology, Nuclear Medicine and Imaging (181 citations), Molecular Biology (562 citations) and Pulmonary and Respiratory Medicine (115 citations). Hui Lyu has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Bolin Liu, Jingcao Huang, Jian Ma, Zhimin He, Jianxiang Wang, Shuiliang Wang, Shuang Liu, Hongbing Liu, Ying Wu and Xuefei Shi. Their work appears in journals such as Cancer Letters, Cancer Research, Biological Procedures Online, Journal of Cellular Biochemistry and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.